The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies

被引:1995
作者
Heim, C [1 ]
Nemeroff, CB [1 ]
机构
[1] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA
关键词
stress; development; animal; human; depression; anxiety;
D O I
10.1016/S0006-3223(01)01157-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epidemiologic studies indicate that children exposed to early adverse experiences are at increased risk for the development of depression, anxiety disorders, or both. Persistent sensitization of central nervous system (CNS) circuits as a consequence of early life stress, which are integrally involved in the regulation of stress and emotion, may represent the underlying biological substrate of art increased vulnerability to subsequent stress as well as to the development of depression and anxiety, A number of preclinical studies suggest that early life stress induces long-lived hyper(re)activity of corticotropin - releasing factor (CRF) systems as well as alterations in other neurotransmitter systems, resulting in increased stress responsiveness. Many of the findings from these preclinical studies are comparable to findings in adult patients with mood and anxiety disorders. Emerging evidence from clinical studies suggests that exposure to early life stress is associated with neurobiological changes in children and adults, which may underlie the increased risk of psychopathology. Current research is focused on strategies to prevent or reverse the detrimental effects of early life stress on the CNS The identification of the neurobiological substrates of early adverse experience is of paramount importance for the development of novel treatments for children, adolescents, and adults.
引用
收藏
页码:1023 / 1039
页数:17
相关论文
共 144 条
[1]   Environmental stress and psychiatric illness [J].
Agid, O ;
Kohn, Y ;
Lerer, B .
BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (03) :135-141
[2]   Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia [J].
Agid, O ;
Shapira, B ;
Zislin, J ;
Ritsner, M ;
Ritsner, M ;
Hanin, B ;
Murad, H ;
Troudart, T ;
Bloch, M ;
Heresco-Levy, U ;
Lerer, B .
MOLECULAR PSYCHIATRY, 1999, 4 (02) :163-172
[3]  
[Anonymous], 3 NATL INCIDENCE STU
[4]   The role of corticotropin-releasing factor in depression and anxiety disorders [J].
Arborelius, L ;
Owens, MJ ;
Plotsky, PM ;
Nemeroff, CB .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) :1-12
[5]  
ARBORELIUS L, 2000, SOC NEUR ABSTR, V26, P867
[6]  
Baker DG, 1999, AM J PSYCHIAT, V156, P585
[7]   CEREBROSPINAL-FLUID NEUROPEPTIDES IN MOOD DISORDER AND DEMENTIA [J].
BANKI, CM ;
KARMACSI, L ;
BISSETTE, G ;
NEMEROFF, CB .
JOURNAL OF AFFECTIVE DISORDERS, 1992, 25 (01) :39-45
[8]   Corticotropin-releasing hormone challenge in prepubertal major depression [J].
Birmaher, B ;
Dahl, RE ;
Perel, J ;
Williamson, DE ;
Nelson, B ;
Stull, S ;
Kaufman, J ;
Waterman, GS ;
Rao, U ;
Nguyen, N ;
PuigAntich, J ;
Ryan, ND .
BIOLOGICAL PSYCHIATRY, 1996, 39 (04) :267-277
[9]   THE ANTIDEPRESSANTS FLUOXETINE, IDAZOXAN AND PHENELZINE ALTER CORTICOTROPIN-RELEASING HORMONE AND TYROSINE-HYDROXYLASE MESSENGER-RNA LEVELS IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS [J].
BRADY, LS ;
GOLD, PW ;
HERKENHAM, M ;
LYNN, AB ;
WHITFIELD, HJ .
BRAIN RESEARCH, 1992, 572 (1-2) :117-125
[10]   LONG-TERM ANTIDEPRESSANT ADMINISTRATION ALTERS CORTICOTROPIN-RELEASING HORMONE, TYROSINE-HYDROXYLASE, AND MINERALOCORTICOID RECEPTOR GENE-EXPRESSION IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS [J].
BRADY, LS ;
WHITFIELD, HJ ;
FOX, RJ ;
GOLD, PW ;
HERKENHAM, M .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :831-837